Cardio Diagnostics Holdings, Inc.
CDIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 104.5% | 1,696.3% | 5.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -23,182.8% | -8,966.9% | -488,945.8% | -67,086.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24,028.2% | -49,087.8% | -490,630% | -68,862.2% |
| EPS Diluted | -9.3 | -19.8 | -45.3 | -1.96 |
| % Growth | 53% | 56.3% | -2,211.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |